Product Program year 2021 Source: CMS Open Payments

Stellant

Device Radiology

Open in the dashboard

General payments

$18,176

12 payments

Research payments

$125,291

4 payments

Through program year 2021, $18,176 in general payments and $125,291 in research payments were reported against Stellant (Radiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2021 Research $30,000 1
2020 General $71 4
2020 Research $25,000 1
2019 General $18,105 8
2019 Research $70,291 2

Breakdown

Who paid General payments · program years 2019–2020
  1. Bayer HealthCare Pharmaceuticals Inc. $18,176 12 payments
Top recipients General payments · program year 2020
  1. Benigno Varela Fernandez Hematology & Oncology · San Juan, PR $25 35% · 1 payment
  2. Luis Cotto Santana Hematology & Oncology · San Juan, PR $25 35% · 1 payment
  3. Alexander Wong Medical Oncology · Sugar Land, TX $20 29% · 1 payment
  4. Madhavi Mummaneni Hematology & Oncology · Orange, CA $1 <1% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $51 71% · 3 practitioners
  2. Medical Oncology Internal Medicine $20 29% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Puerto Rico $50 70% · 2 recipients
  2. Texas $20 29% · 1 recipient
  3. California $1 <1% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

12 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record